
Jeanette M. Lieb
Examiner (ID: 4527, Phone: (571)270-3490 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1675, 1654 |
| Total Applications | 1052 |
| Issued Applications | 767 |
| Pending Applications | 108 |
| Abandoned Applications | 207 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15039163
[patent_doc_number] => 20190330586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => SYSTEM AND METHOD FOR PRODUCTION OF ON-DEMAND PROTEINS IN A PORTABLE UNIT FOR POINT OF CARE DELIVERY
[patent_app_type] => utility
[patent_app_number] => 16/506079
[patent_app_country] => US
[patent_app_date] => 2019-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8256
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16506079
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/506079 | SYSTEM AND METHOD FOR PRODUCTION OF ON-DEMAND PROTEINS IN A PORTABLE UNIT FOR POINT OF CARE DELIVERY | Jul 8, 2019 | Abandoned |
Array
(
[id] => 16893204
[patent_doc_number] => 11034737
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Proteins specific for calcitonin gene-related peptide
[patent_app_type] => utility
[patent_app_number] => 16/504761
[patent_app_country] => US
[patent_app_date] => 2019-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 12
[patent_no_of_words] => 22719
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16504761
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/504761 | Proteins specific for calcitonin gene-related peptide | Jul 7, 2019 | Issued |
Array
(
[id] => 17133641
[patent_doc_number] => 11135175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Active component encapsulated, protected and stabilized within a protein shell
[patent_app_type] => utility
[patent_app_number] => 16/504467
[patent_app_country] => US
[patent_app_date] => 2019-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 12519
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16504467
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/504467 | Active component encapsulated, protected and stabilized within a protein shell | Jul 7, 2019 | Issued |
Array
(
[id] => 15020891
[patent_doc_number] => 20190321450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => Composition and Method for Improving Sleep Duration and Quality
[patent_app_type] => utility
[patent_app_number] => 16/502691
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502691
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/502691 | Composition and method for improving sleep duration and quality | Jul 2, 2019 | Issued |
Array
(
[id] => 19650078
[patent_doc_number] => 12171838
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Polypeptide conjugates for intracellular delivery of nucleic acids
[patent_app_type] => utility
[patent_app_number] => 17/257224
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 21
[patent_no_of_words] => 23822
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257224
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/257224 | Polypeptide conjugates for intracellular delivery of nucleic acids | Jul 1, 2019 | Issued |
Array
(
[id] => 17067290
[patent_doc_number] => 20210269505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => TWEAK-receptor agonists for use in combination with immunotherapy of a cancer
[patent_app_type] => utility
[patent_app_number] => 17/254307
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29589
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254307
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254307 | TWEAK-receptor agonists for use in combination with immunotherapy of a cancer | Jun 27, 2019 | Issued |
Array
(
[id] => 17067278
[patent_doc_number] => 20210269493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER CHARACTERIZED WITH PCSK9 EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/252409
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252409 | Compositions and methods for the treatment of cancer characterized with PCSK9 expression | Jun 24, 2019 | Issued |
Array
(
[id] => 15324093
[patent_doc_number] => 20200002376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => MELANOCORTIN 1 RECEPTOR LIGANDS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/450382
[patent_app_country] => US
[patent_app_date] => 2019-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16450382
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/450382 | Melanocortin 1 receptor ligands and methods of use | Jun 23, 2019 | Issued |
Array
(
[id] => 15527209
[patent_doc_number] => 20200055910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => ANTIMICROBIAL KINOCIDIN COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/448499
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16448499
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/448499 | ANTIMICROBIAL KINOCIDIN COMPOSITIONS AND METHODS OF USE | Jun 20, 2019 | Abandoned |
Array
(
[id] => 16491181
[patent_doc_number] => 10857199
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Compounds and methods for increasing hair growth
[patent_app_type] => utility
[patent_app_number] => 16/444829
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11423
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16444829
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/444829 | Compounds and methods for increasing hair growth | Jun 17, 2019 | Issued |
Array
(
[id] => 17035143
[patent_doc_number] => 20210252101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => LIGAND CONTROLING INTERACTION BETWEEN GAGS WITH THEIR EFFECTOR MOLECULES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/252573
[patent_app_country] => US
[patent_app_date] => 2019-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7278
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252573 | Ligand controling interaction between gags with their effector molecules and use thereof | Jun 16, 2019 | Issued |
Array
(
[id] => 17243476
[patent_doc_number] => 20210363219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => PD-1 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/252233
[patent_app_country] => US
[patent_app_date] => 2019-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 111296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252233
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252233 | PD-1 variant immunomodulatory proteins and uses thereof | Jun 13, 2019 | Issued |
Array
(
[id] => 16842885
[patent_doc_number] => 11014959
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Solvent system for solid phase peptide synthesis
[patent_app_type] => utility
[patent_app_number] => 16/440893
[patent_app_country] => US
[patent_app_date] => 2019-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 12569
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16440893
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/440893 | Solvent system for solid phase peptide synthesis | Jun 12, 2019 | Issued |
Array
(
[id] => 16742074
[patent_doc_number] => 10967043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Agonists of guanylate cyclase and their uses
[patent_app_type] => utility
[patent_app_number] => 16/436401
[patent_app_country] => US
[patent_app_date] => 2019-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24324
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16436401
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/436401 | Agonists of guanylate cyclase and their uses | Jun 9, 2019 | Issued |
Array
(
[id] => 15724313
[patent_doc_number] => 10610571
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-07
[patent_title] => Cytokine conjugates for the treatment of proliferative and infectious diseases
[patent_app_type] => utility
[patent_app_number] => 16/434999
[patent_app_country] => US
[patent_app_date] => 2019-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 24
[patent_no_of_words] => 51571
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16434999
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/434999 | Cytokine conjugates for the treatment of proliferative and infectious diseases | Jun 6, 2019 | Issued |
Array
(
[id] => 14968609
[patent_doc_number] => 20190311783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => METHOD FOR DESIGNING RNA BINDING PROTEIN UTILIZING PPR MOTIF, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/431429
[patent_app_country] => US
[patent_app_date] => 2019-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16431429
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/431429 | Method for designing RNA binding protein utilizing PPR motif, and use thereof | Jun 3, 2019 | Issued |
Array
(
[id] => 16885381
[patent_doc_number] => 20210171576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => METHODS FOR TREATING CANCER WITH ACYLDEPSIPEPTIDE ANALOGS
[patent_app_type] => utility
[patent_app_number] => 15/734185
[patent_app_country] => US
[patent_app_date] => 2019-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734185
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734185 | METHODS FOR TREATING CANCER WITH ACYLDEPSIPEPTIDE ANALOGS | Jun 2, 2019 | Abandoned |
Array
(
[id] => 16778034
[patent_doc_number] => 20210115112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => FIBROSIS-INHIBITING COMPOSITION, CELLS PRODUCING SAME, AND CELL SHEET COMPRISING SAID CELLS
[patent_app_type] => utility
[patent_app_number] => 16/972285
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16972285
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/972285 | Fibrosis-inhibiting composition, cells producing same, and cell sheet comprising said cells | May 29, 2019 | Issued |
Array
(
[id] => 15646761
[patent_doc_number] => 20200085910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => POLYPEPTIDE-POLYMER CONJUGATES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/425492
[patent_app_country] => US
[patent_app_date] => 2019-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16425492
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/425492 | POLYPEPTIDE-POLYMER CONJUGATES AND METHODS OF USE THEREOF | May 28, 2019 | Abandoned |
Array
(
[id] => 17028503
[patent_doc_number] => 11090301
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => Treatment of joint conditions
[patent_app_type] => utility
[patent_app_number] => 16/416710
[patent_app_country] => US
[patent_app_date] => 2019-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7490
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16416710
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/416710 | Treatment of joint conditions | May 19, 2019 | Issued |